Implementation of evidence-based antenatal care in Mozambique: A cluster randomized controlled trial

Conditions

Haematological Disorders HIV/AIDS Malaria Pregnancy and Childbirth Anaemia, syphilis

Betrán AP, Bergel E, Griffin S, Melo A, Nguyen MH, Carbonell A, Mondlane S, Merialdi M, Temmerman M, Gülmezoglu AM, WHO Antenatal Care Trial in Mozambique Research Group.

2018-01-0124 citations

10.1016/s2214-109x(17)30421-7

Implementation of evidence-based antenatal care in Mozambique: a cluster randomized controlled trial: study protocol.

Chavane L, Merialdi M, Betrán AP, Requejo-Harris J, Bergel E, Aleman A, Colomar M, Cafferata ML, Carbonell A, Crahay B, Delvaux T, Geelhoed D, Gülmezoglu M, Malapende CR, Melo A, Nguyen MH, Osman NB, Widmer M, Temmerman M, Althabe F.

2014-05-2114 citations

10.1186/1472-6963-14-228

Interventions

ANC integrated package through kits

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women arriving for antenatal care in the 10 selected facilities

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Frequency of women receiving screening for syphilis at least once during pregnancy;Frequency of women receiving screening for HIV in first ANC visit ;Frequency of women receiving screening for hypertension;Frequency of women receiving intermittent preventive malaria treatment (1, 2 doses);Frequency of women receiving screening for anaemia;Frequency of women receiving tetanus toxoid;Frequency of women receiving iron supplementation ;Frequency of women receiving anti-parasitic treatment for anaemia prevention ;Frequency of sero-positive women receiving the administration of syphilis treatment (1,2 or 3 doses) ;Frequency of sero-positive women receiving administration of antiretroviral treatment (regimen and duration)	—

Measure

Time frame

Frequency of women receiving screening for syphilis at least once during pregnancy;Frequency of women receiving screening for HIV in first ANC visit ;Frequency of women receiving screening for hypertension;Frequency of women receiving intermittent preventive malaria treatment (1, 2 doses);Frequency of women receiving screening for anaemia;Frequency of women receiving tetanus toxoid;Frequency of women receiving iron supplementation ;Frequency of women receiving anti-parasitic treatment for anaemia prevention ;Frequency of sero-positive women receiving the administration of syphilis treatment (1,2 or 3 doses) ;Frequency of sero-positive women receiving administration of antiretroviral treatment (regimen and duration)

—

Secondary

Measure	Time frame
Frequency of midwives¿ positives attitudes and readiness to provide the selected practices	—

Countries

Mozambique

Contacts

Public ContactAna Pilar Betrán

Medical Officer, Department of Reproductive Health and Research, World Health Organization

betrana@who.int+41 22 791 4205

Outcome results

None listed